REGENXBIO Inc. (RGNX) Debt-to-equity % [USD] 2016 - 2024

Historical data

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
REGENXBIO Inc. quarterly Debt-to-equity history and growth rate from 2016 to 2024.
  • REGENXBIO Inc. Debt-to-equity for the quarter ending March 31, 2024 was 71.2 %, a 24.7% increase year-over-year.
Debt-to-equity, Quarterly (% [USD])
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 71.2 +14.1 +24.7% Mar 31, 2024
Q4 2023 70.7 +16.7 +30.9% Dec 31, 2023
Q3 2023 65.5 +15.4 +30.7% Sep 30, 2023
Q2 2023 61.3 +8.4 +15.9% Jun 30, 2023
Q1 2023 57.1 +1.25 +2.24% Mar 31, 2023
Q4 2022 54 -4.72 -8.04% Dec 31, 2022
Q3 2022 50.2 -19.5 -28% Sep 30, 2022
Q2 2022 52.9 -6.92 -11.6% Jun 30, 2022
Q1 2022 55.9 +8.17 +17.1% Mar 31, 2022
Q4 2021 58.7 +24.5 +71.5% Dec 31, 2021
Q3 2021 69.6 +53.7 +336% Sep 30, 2021
Q2 2021 59.8 +49.2 +464% Jun 30, 2021
Q1 2021 47.7 +38.6 +424% Mar 31, 2021
Q4 2020 34.2 +26.1 +319% Dec 31, 2020
Q3 2020 16 +8.7 +120% Sep 30, 2020
Q2 2020 10.6 +4.44 +72% Jun 30, 2020
Q1 2020 9.1 +3.2 +54.2% Mar 31, 2020
Q4 2019 8.16 +2.45 +42.9% Dec 31, 2019
Q3 2019 7.27 +1.61 +28.4% Sep 30, 2019
Q2 2019 6.17 -0.56 -8.32% Jun 30, 2019
Q1 2019 5.9 -0.94 -13.7% Mar 31, 2019
Q4 2018 5.71 -1.04 -15.4% Dec 31, 2018
Q3 2018 5.66 -0.68 -10.7% Sep 30, 2018
Q2 2018 6.73 +0.12 +1.82% Jun 30, 2018
Q1 2018 6.84 +0.47 +7.37% Mar 31, 2018
Q4 2017 6.75 +0.99 +17.2% Dec 31, 2017
Q3 2017 6.34 +1.77 +38.8% Sep 30, 2017
Q2 2017 6.61 +3.48 +111% Jun 30, 2017
Q1 2017 6.37 Mar 31, 2017
Q4 2016 5.76 Dec 31, 2016
Q3 2016 4.56 Sep 30, 2016
Q2 2016 3.13 Jun 30, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.